Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap | 34.15M | P/E | - | EPS this Y | - | Ern Qtrly Grth | - |
Income | -24.09M | Forward P/E | -2.61 | EPS next Y | 22.00% | 50D Avg Chg | -40.00% |
Sales | 27.65M | PEG | - | EPS past 5Y | - | 200D Avg Chg | -63.00% |
Dividend | N/A | Price/Book | N/A | EPS next 5Y | - | 52W High Chg | -82.00% |
Recommedations | 2.00 | Quick Ratio | 0.71 | Shares Outstanding | 17.39M | 52W Low Chg | 9.00% |
Insider Own | 20.64% | ROA | -40.15% | Shares Float | 8.09M | Beta | 0.21 |
Inst Own | 57.01% | ROE | - | Shares Shorted/Prior | 73.91K/152.97K | Price | 2.09 |
Gross Margin | 50.67% | Profit Margin | -87.14% | Avg. Volume | 13,595 | Target Price | 2.50 |
Oper. Margin | -63.92% | Earnings Date | - | Volume | 3,294 | Change | -0.24% |
About ProSomnus, Inc.
ProSomnus, Inc. operates as a medical technology company that develops, manufactures, and markets precision intraoral medical devices for treating and managing patients with obstructive sleep apnea. The company sells its products to sleep dentists, sleep physicians, primary care providers, otolaryngologists, and other integrated healthcare service providers through a direct sales force. ProSomnus, Inc. is headquartered in Pleasanton, California.
ProSomnus, Inc. News